Guifeng Lin

1.2k total citations
26 papers, 441 citations indexed

About

Guifeng Lin is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Guifeng Lin has authored 26 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Guifeng Lin's work include Cannabis and Cannabinoid Research (4 papers), Receptor Mechanisms and Signaling (4 papers) and DNA Repair Mechanisms (3 papers). Guifeng Lin is often cited by papers focused on Cannabis and Cannabinoid Research (4 papers), Receptor Mechanisms and Signaling (4 papers) and DNA Repair Mechanisms (3 papers). Guifeng Lin collaborates with scholars based in China, Thailand and United States. Guifeng Lin's co-authors include Shengyong Yang, Linli Li, Anjie Xia, Jingming Liu, Luyi Huang, Xin Yang, Shenzhen Huang, Yangli Zhou, Zhenhua Shao and Jingxin Qiao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Guifeng Lin

26 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guifeng Lin China 11 306 51 49 47 45 26 441
Wen Zhu China 13 176 0.6× 18 0.4× 10 0.2× 21 0.4× 28 0.6× 28 384
Hannah Wapenaar Netherlands 9 317 1.0× 40 0.8× 30 0.6× 15 0.3× 55 1.2× 12 407
Olga Abramczyk United States 13 400 1.3× 26 0.5× 20 0.4× 27 0.6× 51 1.1× 14 536
Anja Berger Germany 15 439 1.4× 51 1.0× 27 0.6× 21 0.4× 43 1.0× 20 583
Junya Kohroki Japan 14 278 0.9× 80 1.6× 18 0.4× 27 0.6× 63 1.4× 23 492
Raquel Gomez Netherlands 9 217 0.7× 37 0.7× 12 0.2× 145 3.1× 68 1.5× 13 466
Shu Liu China 8 178 0.6× 53 1.0× 14 0.3× 35 0.7× 53 1.2× 15 342
Ellin‐Kristina Hillert Sweden 8 279 0.9× 35 0.7× 15 0.3× 37 0.8× 106 2.4× 8 418
Brandon White United States 11 653 2.1× 42 0.8× 47 1.0× 28 0.6× 113 2.5× 18 791
Fabio Manzo Italy 8 425 1.4× 38 0.7× 47 1.0× 14 0.3× 74 1.6× 11 511

Countries citing papers authored by Guifeng Lin

Since Specialization
Citations

This map shows the geographic impact of Guifeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guifeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guifeng Lin more than expected).

Fields of papers citing papers by Guifeng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guifeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guifeng Lin. The network helps show where Guifeng Lin may publish in the future.

Co-authorship network of co-authors of Guifeng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Guifeng Lin. A scholar is included among the top collaborators of Guifeng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guifeng Lin. Guifeng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chao, Guifeng Lin, Xin Yang, et al.. (2024). Structure-based identification of a G protein–biased allosteric modulator of cannabinoid receptor CB1. Proceedings of the National Academy of Sciences. 121(24). e2321532121–e2321532121. 13 indexed citations
2.
Lin, Guifeng, Anjie Xia, Jingxin Qiao, et al.. (2024). Identification of a new class of activators of the Hippo pathway with antitumor activity in vitro and in vivo. Biochemical Pharmacology. 224. 116217–116217. 2 indexed citations
3.
Zhang, Yun, Jiao Yan, Anjie Xia, et al.. (2023). Discovery of a novel pyroptosis inhibitor acting though modulating glutathionylation to suppress NLRP3-related signal pathway. International Immunopharmacology. 127. 111314–111314. 5 indexed citations
4.
Zhou, Pei, Jinlong Zhao, Qian Hu, et al.. (2023). Discovery of (S)-3-(4-(benzyloxy)phenyl)-2-(2-phenoxyacetamido)propanoic acid derivatives as a new class of GPR34 antagonists. Bioorganic & Medicinal Chemistry Letters. 97. 129548–129548. 2 indexed citations
5.
Zhang, Yun, Jiao Yan, Guifeng Lin, et al.. (2023). Targeting Noncanonical Pyroptosis With a Small Molecular Inhibitor Alleviates Inflammation in the LPS-Induced Keratitis Mouse Model. Investigative Ophthalmology & Visual Science. 64(1). 1–1. 5 indexed citations
6.
Yang, Xin, Xuehui Wang, Zheng Xu, et al.. (2022). Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1. Nature Chemical Biology. 18(8). 831–840. 67 indexed citations
7.
Yan, Jiao, Bo Mu, Yun Zhang, et al.. (2022). Discovery of a novel and potent inhibitor with differential species-specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis. European Journal of Medicinal Chemistry. 232. 114194–114194. 43 indexed citations
8.
Liu, Nan, Lifang Zhou, Guifeng Lin, et al.. (2022). HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing. Molecular Therapy — Nucleic Acids. 29. 36–46. 40 indexed citations
9.
10.
Chen, Pei, Yan Jiao, Guifeng Lin, et al.. (2022). Discovery of 6,7-dihydro-5H-pyrrolo[3,4-d] pyrimidine derivatives as a new class of ATR inhibitors. Bioorganic & Medicinal Chemistry Letters. 63. 128651–128651. 8 indexed citations
11.
Yang, Xin, Guifeng Lin, Anjie Xia, et al.. (2022). Discovery of Small Molecule Agonist of Gonadotropin-Releasing Hormone Receptor (GnRH1R). Journal of Chemical Information and Modeling. 62(20). 5009–5022. 7 indexed citations
12.
Zhang, Yun, Anjie Xia, Shiyu Zhang, et al.. (2021). Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 41. 127881–127881. 5 indexed citations
13.
Li, Yueshan, Zhuang Miao, Ruicheng Yang, et al.. (2021). Discovery of 3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one derivatives as a new class of ROCK inhibitors for the treatment of glaucoma. Bioorganic & Medicinal Chemistry Letters. 45. 128138–128138. 5 indexed citations
14.
Mao, Xin, Liang Xiong, Anjie Xia, et al.. (2021). Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor Domain. Angewandte Chemie. 133(16). 8842–8847. 1 indexed citations
15.
Huang, Shenzhen, Xiang Wang, Guifeng Lin, et al.. (2019). Discovery of human TyrRS inhibitors by structure-based virtual screening, structural optimization, and bioassays. RSC Advances. 9(16). 9323–9330. 2 indexed citations
16.
Qiao, Jingxin, Guifeng Lin, Anjie Xia, et al.. (2019). Discovery of 1,8-disubstituted-[1,2,3]triazolo[4,5-c]quinoline derivatives as a new class of Hippo signaling pathway inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(18). 2595–2603. 8 indexed citations
17.
18.
Sun, Qizheng, Guifeng Lin, Linli Li, et al.. (2017). Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers. Journal of Medicinal Chemistry. 60(14). 6337–6352. 36 indexed citations
19.
Liu, Xiao, Guoqing Hu, Hongbo He, et al.. (2016). Linking microbial immobilization of fertilizer nitrogen to in situ turnover of soil microbial residues in an agro-ecosystem. Agriculture Ecosystems & Environment. 229. 40–47. 35 indexed citations
20.
Wang, Yanhong, Hong Zhang, Shi‐Cheng Wang, et al.. (2010). Preparation and Application of Atrazine Molecularly Imprinted Solid Phase Extraction Pillar. CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION). 38(5). 678–682. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen Zhu Breakdown of academic impact, for papers by Hannah Wapenaar Breakdown of academic impact, for papers by Olga Abramczyk Breakdown of academic impact, for papers by Anja Berger Breakdown of academic impact, for papers by Junya Kohroki Breakdown of academic impact, for papers by Raquel Gomez Breakdown of academic impact, for papers by Shu Liu Breakdown of academic impact, for papers by Ellin‐Kristina Hillert Breakdown of academic impact, for papers by Brandon White Breakdown of academic impact, for papers by Fabio Manzo
Rankless by CCL
2026